CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-03 | Coric Vlad Chief Executive Officer | Other acquisition | +249,130 | 249,130 | ||
| 2022-10-03 | Coric Vlad Chief Executive Officer | Other acquisition | +156,750 | 156,750 | ||
| 2022-10-03 | Coric Vlad Chief Executive Officer | Other acquisition | +9,565 | 9,565 | ||
| 2022-10-03 | CHILDS JOHN W Director | Other acquisition | +1,512,500 | 1,517,110 | ||
| 2022-10-03 | CHILDS JOHN W Director | Other acquisition | +5,000 | 5,000 | ||
| 2022-10-03 | Heffernan Michael Thomas Director | Other acquisition | +1,660 | 1,660 | ||
| 2022-10-03 | Heffernan Michael Thomas Director | Option exercise | +4,119 | $4.84 | $20K | 5,779 |
| 2022-10-03 | Heffernan Michael Thomas Director | Option exercise | +5,998 | $3.56 | $21K | 11,777 |
| 2022-10-03 | Heffernan Michael Thomas Director | Option exercise | +13,100 | $2.40 | $31K | 24,877 |
| 2022-10-03 | Heffernan Michael Thomas Director | Shares withheld for taxes | −5,507 | $7.50 | $41K | 19,370 |
| 2022-10-03 | Heffernan Michael Thomas Director | Other acquisition · Stock Options (Right to Buy) | +4,119 | 4,119 | ||
| 2022-10-03 | Heffernan Michael Thomas Director | Other acquisition · Stock Options (Right to Buy) | +5,998 | 5,998 | ||
| 2022-10-03 | Heffernan Michael Thomas Director | Other acquisition · Stock Options (Right to Buy) | +13,100 | 13,100 | ||
| 2022-10-03 | Heffernan Michael Thomas Director | Option exercise · Stock Options (Right to Buy) | −4,119 | 0 | ||
| 2022-10-03 | Heffernan Michael Thomas Director | Option exercise · Stock Options (Right to Buy) | −5,998 | 0 | ||
| 2022-10-03 | Heffernan Michael Thomas Director | Option exercise · Stock Options (Right to Buy) | −13,100 | 0 | ||
| 2022-10-03 | Heffernan Michael Thomas Director | Grant or award · Stock Options (Right to Buy) | +125,000 | 125,000 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Other acquisition | +5,826 | 5,826 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Other acquisition | +6,500 | 12,326 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Other acquisition | +3,750 | 16,076 |
Page 9 of 18 · 355 trades